Current filters:


1 to 9 of 25 results

Merck & Co drug gets first nod under PIP


The European Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) has made…

CancidasCaspofungin AcetateMerck KGaA

Merck & Co's Cancidas gets expanded US label


US drug major Merck & Co says that the Food and Drug Administration has approved an expanded label for…

CancidasCaspofungin AcetateMerck KGaA

EMEA's PDCO issues PIP review opinions


The European Medicines Agency's (EMEA) Pediatric Committee (PDCO) has adopted opinions on pediatric investigation…

CancidasCaspofungin AcetateCozaarHyzaarLosartan PotassiumLosartan Potassium-HydrochlorothiazideMerck KGaAMontelukast SodiumPfizerSingulair

Merck & Co returns to India


US drug major Merck & Co has said that it will restart operations at its wholly-owned subsidiary MSD…

AggrastatCancidasCaspofungin AcetateErtapenem InjectionInvanzMerck KGaAPneumococcal Vaccine PolyvalentPneumovaxTirofibanVaricella Virus Vaccine LiveVarivax

Vicuron antifungal promising in Phase II


Vicuron Pharmaceuticals, born out of the merger of Versicor with Biosearch Italia (Marketletters passim),…

AbelcetAmbisomeAmphotericin BAnidulafunginCancidasCaspofungin AcetateDiflucanEraxisFluconazoleFungizoneMerck KGaA

Vicuron files NDA for anidulafungin in USA


Vicuron Pharmaceuticals of the USA, born out of the merger of Versicorwith Biosearch Italia (Marketletters…

AnidulafunginCancidasCaspofungin AcetateEraxisMerck KGaA

1 to 9 of 25 results

Back to top